SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,917.85 1,225.07
( 1.62%)

Global Indices

Nasdaq

52,165.19 373.88
(0.72%)

Dow Jones

7,596.72 -4.35
(-0.06%)

Hang Seng

63,112.86 -177.25
(-0.28%)

Nikkei 225

10,659.07 -102.26
(-0.95%)

Forex

USD-INR

94.93 -0.28
(-0.30%)

EUR-INR

105.90 -0.29
(-0.27%)

GBP-INR

127.09 0.08
(0.06%)

JPY-INR

0.60 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

200.4589991

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

FREDUN

54.29

2412.72

EPS(TTM)

Face Value()

Div & Yield %

25.95

0.02

Back

Bajaj Finserv consolidated net profit rises 12.31% in the June 2026 quarter

Jul 31,2026

Net profit of Bajaj Finserv rose 12.31% to Rs 3132.35 crore in the quarter ended June 2026 as against Rs 2789.05 crore during the previous quarter ended June 2025. Sales rose 19.37% to Rs 41670.09 crore in the quarter ended June 2026 as against Rs 34907.91 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	41670.09	34907.91	19
OPM %	41.13	41.01	-
PBDT	9311.87	7520.97	24
PBT	8932.19	7203.64	24
NP	3132.35	2789.05	12

76,917.85 1,225.07 ( 1.62%)

52,165.19 373.88 (0.72%)

7,596.72 -4.35 (-0.06%)

63,112.86 -177.25 (-0.28%)

10,659.07 -102.26 (-0.95%)

94.93 -0.28 (-0.30%)

105.90 -0.29 (-0.27%)

127.09 0.08 (0.06%)

0.60 0.00 (-0.15%)